Back to all studies
CompletedNCT00812461

20 mg Nalmefene, for Alcohol Dependence

This study is completed in France, in Belgium, in Czechia, .... It is testing 20 mg Nalmefene, for Alcohol Dependence.

Mental health, Alcohol DependenceDrugOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Nalmefene may be useful for adults experiencing mental health.

What would participation involve?

Participants may receive Nalmefene, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Belgium, in Czechia, and in France.

Who is it mainly for?

This study appears to be mainly for adults with mental health.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateMarch 2009
Recruitment status
Completed
Enrollment listed in the registry
678
Sponsor
H. Lundbeck A/S
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
France, Belgium, Czechia, ...
Age range
Over 18 Years
Official registry ID
NCT00812461
Official title
Nalmefene Efficacy Study II: Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy Study of 20 mg Nalmefene, as Needed Use, in Patients With Alcohol Dependence

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00812461. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Belgium · 7 sites
  • BE002
    Assebroek
    Site status: Not listed — confirm with the team
  • BE007
    Bruges
    Site status: Not listed — confirm with the team
  • BE006
    Charleroi
    Site status: Not listed — confirm with the team
  • BE005
    Kortenberg
    Site status: Not listed — confirm with the team
  • BE001
    Liège
    Site status: Not listed — confirm with the team
  • BE003
    Mechelen
    Site status: Not listed — confirm with the team
  • BE004
    Ostend
    Site status: Not listed — confirm with the team
Czechia · 3 sites
  • CZ001
    Litoměřice
    Site status: Not listed — confirm with the team
  • CZ002
    Prague
    Site status: Not listed — confirm with the team
  • CZ003
    Prague
    Site status: Not listed — confirm with the team
France · 16 sites
  • FR008
    Angers
    Site status: Not listed — confirm with the team
  • FR004
    Bully-les-Mines
    Site status: Not listed — confirm with the team
  • FR009
    Clichy
    Site status: Not listed — confirm with the team
  • FR012
    Élancourt
    Site status: Not listed — confirm with the team
  • FR021
    La Rochelle
    Site status: Not listed — confirm with the team
  • FR011
    Le Pecq
    Site status: Not listed — confirm with the team
  • FR019
    Lille
    Site status: Not listed — confirm with the team
  • FR016
    Lyon
    Site status: Not listed — confirm with the team
  • FR014
    Nancy
    Site status: Not listed — confirm with the team
  • FR015
    Nîmes
    Site status: Not listed — confirm with the team
  • FR002
    Rennes
    Site status: Not listed — confirm with the team
  • FR001
    Sartrouville
    Site status: Not listed — confirm with the team
  • FR007
    Strasbourg
    Site status: Not listed — confirm with the team
  • FR005
    Toulouse
    Site status: Not listed — confirm with the team
  • FR006
    Toulouse
    Site status: Not listed — confirm with the team
  • FR003
    Villejuif
    Site status: Not listed — confirm with the team
Italy · 10 sites
  • IT017
    Bologna
    Site status: Not listed — confirm with the team
  • IT013
    Bologna
    Site status: Not listed — confirm with the team
  • IT008
    Cento
    Site status: Not listed — confirm with the team
  • IT006
    Florence
    Site status: Not listed — confirm with the team
  • IT002
    Parma
    Site status: Not listed — confirm with the team
  • IT007
    Rome
    Site status: Not listed — confirm with the team
  • IT001
    Rome
    Site status: Not listed — confirm with the team
  • IT011
    Rome
    Site status: Not listed — confirm with the team
  • IT004
    Rome
    Site status: Not listed — confirm with the team
  • IT018
    Soverato Marina
    Site status: Not listed — confirm with the team
Poland · 7 sites
  • PL005
    Gdansk
    Site status: Not listed — confirm with the team
  • PL004
    Leszno
    Site status: Not listed — confirm with the team
  • PL006
    Lublin
    Site status: Not listed — confirm with the team
  • PL007
    Lublin
    Site status: Not listed — confirm with the team
  • PL002
    Piekary Śląskie
    Site status: Not listed — confirm with the team
  • PL003
    Skorzewo
    Site status: Not listed — confirm with the team
  • PL001
    Szczecin
    Site status: Not listed — confirm with the team
Portugal · 4 sites
  • PT003
    Angra do Heroísmo
    Site status: Not listed — confirm with the team
  • PT002
    Lisbon
    Site status: Not listed — confirm with the team
  • PT001
    Lisbon
    Site status: Not listed — confirm with the team
  • PT006
    Mem Martins
    Site status: Not listed — confirm with the team
Spain · 10 sites
  • ES005
    Alicante
    Site status: Not listed — confirm with the team
  • ES006
    Barcelona
    Site status: Not listed — confirm with the team
  • ES008
    Barcelona
    Site status: Not listed — confirm with the team
  • ES004
    Barcelona
    Site status: Not listed — confirm with the team
  • ES014
    Burgos
    Site status: Not listed — confirm with the team
  • ES010
    Madrid
    Site status: Not listed — confirm with the team
  • ES001
    Mallorca
    Site status: Not listed — confirm with the team
  • ES002
    Oviedo
    Site status: Not listed — confirm with the team
  • ES003
    Valencia
    Site status: Not listed — confirm with the team
  • ES011
    Zamora
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with mental health. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Placebo, Nalmefene. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Are there criteria about substance use or wanting to reduce it?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by H. Lundbeck A/S, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me